Menu

Image of the Day: Morphing Cells

By removing a single gene, researchers change the developmental fate of tumor cells in mice.  

Mar 27, 2018
The Scientist Staff, The Scientist Staff

Stomach and intestinal cells found in mouse lung tumorsTATA LAB, DUKE UNIVERSITY

Researchers at Duke University School of Medicine have prompted cells normally found in the gastrointestinal tract to grow within lung tumors in mice.

They had analyzed lung cancer data from the Cancer Genome Atlas Research Network, a large consortium of genomes of cancer samples, and found lung cancer cells often lacked a gene called NKX2-1. They knocked it out in healthy mice and then activated the oncogenes SOX2 or KRAS to give them cancer. When the researchers examined the tumors from mice that lacked NKX2-1, they found some tumor cells had developed into gastrointestinal cells, their closest developmental counterpart.  

“Cancer cells will do whatever it takes to survive,” says Purushothama Rao Tata, a cell biologist at Duke University School of Medicine, in a statement. “Upon treatment with chemotherapy, lung cells shut down some of the key cell regulators and pick up the characteristics of other cells in order to gain resistance.”

P.R. Tata el al., “Developmental history provides a roadmap for the emergence of tumor plasticity,” Developmental Cell, doi:10.1016/j.devcel.2018.02.024, 2018.

 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.